By Services
Online Inquiry

By Services

As a leading research service provider, Protheragen has established a comprehensive, end-to-end therapy development platform to accelerate the translation of innovative therapeutics for a wide range of ophthalmic diseases. Our one-stop pre-clinical approach integrates cutting-edge technologies, deep scientific expertise, and seamless cross-functional collaboration to systematically advance promising drug and therapy candidates through the critical pre-clinical phase.

Diagnostics Development Services

Protheragen is committed to pushing the boundaries of diagnostic technology. Our pre-clinical diagnostics development services focus on creating tools that can detect ophthalmic diseases at their earliest stages.

Therapeutics Development Services

From small-molecule inhibitors and biologics to gene therapies and regenerative approaches, our researchers work tirelessly to translate the latest scientific breakthroughs into promising pre-clinical leads.

Disease Model Development Services

Our team has established a comprehensive suite of advanced in vitro and in vivo models, including organotypic cultures, patient-derived xenografts, and genetically engineered animal systems, to recapitulate the complexities of ophthalmic diseases.

Drug Safety Evaluation Services

Ensuring the safety and tolerability of ophthalmic drug candidates is a top priority for Protheragen. Our pre-clinical drug safety evaluation services encompass extensive toxicology studies and ocular irritation assessments.

Pharmacokinetics Services

Our pharmacokinetics experts leverage advanced modeling and simulation techniques, coupled with in-depth bioavailability studies, to guide the formulation and optimization of innovative drug delivery system.

Customized Services

With a wealth of expertise and a highly skilled team, our company delivers tailored research services for ophthalmic disease drugs and therapies, catering to the diverse requirements of our clientele.

By seamlessly integrating these pre-clinical capabilities, Protheragen offers a truly one-stop solution for advancing ophthalmic disease therapies from concept to the clinical trial stage. Our cross-functional teams work in close collaboration to identify and address challenges at every step of the development pipeline, ensuring the rapid and efficient progression of promising candidates. If you are interested in our services, please feel free to contact us for more details and quotation information of related services.

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

x